News

The global, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial will evaluate disease remission in these patients treated with subcutaneous ofatumumab as add-on treatment to oral steroids. In Pemphigus vulgaris,

In 2008, Humira was approved in the US for polyarticular juvenile idiopathic arthritis (JIA) in patients aged four years and older. AbbVie Pharmaceutical Development vice-president Scott Brun said

GA is the severe stage of the dry form of age-related macular degeneration (dry-AMD). OpRegen includes retinal pigment epithelial (RPE) cells derived from human embryonic stem cells and

ARIAD will receive $50 million in exchange for a fully paid up license to this technology and return of its equity stake in closely held Bellicum. The scope

If the merger deal was successful, Salix would have been combined with, and become a wholly-owned subsidiary of, Cosmo Technologies, a subsidiary of Cosmo. As part of the

18-MC is an alpha-3-beta-4 nicotinic receptor antagonist that modulates excessive dopamine fluctuations in the mesolimbic system of the brain and this mechanism of action differs from all existing

These requests were made by treating physicians. Emergency Investigational New Drug Applications (EIND) were granted by the U.S. Food and Drug Administration (FDA). "Chimerix is committed to working

The agreement represents an innovative approach to research by focusing numerous clinical trials using multiple agents, in mono and combination regimens, on a specific disease target, in this

The company expects to release final results of the study in the fourth quarter of 2014 upon completion of statistical analysis. Preliminary interim data from this study were